Boston Scientific (MEX:BSX) Asset Turnover: 0.12 (As of Mar. 2026)


MEX:BSX Boston Scientific Corp MEX:BSX
85 GF Score
Price MXN777.00
GF Value MXN1,852.47
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Boston Scientific Asset Turnover?

Boston Scientific MEX:BSX -1.65% 85 Asset Turnover is 0.12 as of Mar. 2026. GuruFocus rates MEX:BSX with a GF Score™ of 85/100 and a GF Value™ of MXN1,852.47 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Boston Scientific's Revenue for the three months ended in Mar. 2026 was MXN93,824 Mil. Boston Scientific's Total Assets for the quarter that ended in Mar. 2026 was MXN793,066 Mil. Therefore, Boston Scientific's Asset Turnover for the quarter that ended in Mar. 2026 was 0.12.

Asset Turnover is linked to ROE % through Du Pont Formula. Boston Scientific's annualized ROE % for the quarter that ended in Mar. 2026 was 21.43%. It is also linked to ROA % through Du Pont Formula. Boston Scientific's annualized ROA % for the quarter that ended in Mar. 2026 was 12.20%.


Boston Scientific  (MEX:BSX) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Boston Scientific's annulized ROE % for the quarter that ended in Mar. 2026 is

ROE %**(Q: Mar. 2026 )
=Net Income/Total Stockholders Equity
=96727.404/451355.938
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(96727.404 / 375296.552)*(375296.552 / 793065.6075)*(793065.6075/ 451355.938)
=Net Margin %*Asset Turnover*Equity Multiplier
=25.77 %*0.4732*1.7571
=ROA %*Equity Multiplier
=12.20 %*1.7571
=21.43 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Boston Scientific's annulized ROA % for the quarter that ended in Mar. 2026 is

ROA %(Q: Mar. 2026 )
=Net Income/Total Assets
=96727.404/793065.6075
=(Net Income / Revenue)*(Revenue / Total Assets)
=(96727.404 / 375296.552)*(375296.552 / 793065.6075)
=Net Margin %*Asset Turnover
=25.77 %*0.4732
=12.20 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Boston Scientific Asset Turnover Related Terms


Boston Scientific Asset Turnover Historical Data

* Premium members only.

The historical data trend for Boston Scientific's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Boston Scientific Asset Turnover Chart

Boston Scientific Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.38 0.38 0.39 0.49 0.45

Boston Scientific Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.12 0.12 0.12 0.12

MEX:BSX vs EW, GEHC, MDT: Asset Turnover Comparison

For the Medical Devices subindustry, Boston Scientific's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Boston Scientific Asset Turnover vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Boston Scientific's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Boston Scientific's Asset Turnover falls into.


MEX:BSX
85GF Score
Boston Scientific Corp MEX:BSX
Asset Turnover is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Boston Scientific Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Boston Scientific's Asset Turnover for the fiscal year that ended in Dec. 2025 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2025 )/( (Total Assets (A: Dec. 2024 )+Total Assets (A: Dec. 2025 ))/ count )
=361446.422/( (821610.301+786362.937)/ 2 )
=361446.422/803986.619
=0.45

Boston Scientific's Asset Turnover for the quarter that ended in Mar. 2026 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=93824.138/( (786362.937+799768.278)/ 2 )
=93824.138/793065.6075
=0.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.

Frequently Asked Questions Learn more about Asset Turnover →
What does a Asset Turnover of 0.12 mean?
Boston Scientific (MEX:BSX) has a Asset Turnover of 0.12 as of Mar. 2026. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Boston Scientific and its competitors.
Is Boston Scientific's Asset Turnover too high?
Boston Scientific's current Asset Turnover is 0.12. Overall, Boston Scientific has a GF Score™ of 85/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Boston Scientific's Asset Turnover compare to EW and GEHC?
Boston Scientific's Asset Turnover of 0.12 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Asset Turnover for a Medical Devices & Instruments company?
A good Asset Turnover depends on the Medical Devices & Instruments industry context. However, Asset Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Asset Turnover mean?
A high Asset Turnover can signal that a stock is expensive relative to its fundamentals. Asset turnover equals current-period sales over average total assets over the past two periods. View historical data on Boston Scientific and its competitors. Boston Scientific's current Asset Turnover is 0.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Boston Scientific stock overvalued right now?
Based on GuruFocus' analysis, Boston Scientific (MEX:BSX) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,852.47, compared to a current price of MXN777.00 — trading 58.1% below its estimated fair value. The current Asset Turnover is 0.12. Boston Scientific's overall GF Score™ is 85/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Asset Turnover calculated?
Asset Turnover is calculated from a company's financial statements. For Boston Scientific (MEX:BSX), the current Asset Turnover is 0.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Boston Scientific (MEX:BSX) Overvalued in 2026?

Based on GuruFocus' analysis, Boston Scientific stock appears to be undervalued. The current stock price of MXN777.00 is trading 58.1% below its estimated GF Value™ of MXN1,852.47. GuruFocus considers Boston Scientific to be Significantly Undervalued.

Key valuation signals for MEX:BSX:

  • Asset Turnover: 0.12
  • GF Value™: MXN1,852.47 vs. price of MXN777.00 (58.1% below fair value)
  • GF Score™: 85/100 with 1 warning sign

No single metric tells the full story. See the MEX:BSX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Boston Scientific Business Description

Address 300 Boston Scientific Way, Marlborough, MA, USA, 01752-1234
Boston Scientific produces less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.
85GF Score

Get the complete analysis for MEX:BSX

Asset Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN777.00
Price
MXN1,852.47
GF Value